Longjin Biotechnology
Haicang
About Longjin Biotechnology
Longjin Biotechnology is a biopharmaceutical company committed to the development of genetic diagnostic reagents for tumor molecular targeted therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $4.5M
- Last round: Corporate Round (Feb 2024)
- Website: diaglogic.com
Industries & Categories
Biopharma, Biotechnology, Health Care
Canonical: https://fsome.com/organization/longjin-biotechnology-110231 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.